| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |